Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years
Heart and Vessels(2024)
Abstract
Awareness of transthyretin amyloid cardiomyopathy (ATTR-CM) has increased over the years due to diagnostic and therapeutic developments. Timely initiation of novel disease-modifying treatments improves both morbidity and mortality, which underlines the necessity for a prompt diagnosis. Nevertheless, early diagnosis of ATTR-CM remains challenging. This is a retrospective observational cohort study of patients diagnosed with ATTR-CM. Between 2016 and 2023, 87 patients were diagnosed with cardiac amyloidosis of which 65 (75
MoreTranslated text
Key words
Cardiac amyloidosis,Diagnostic trajectory,Diagnostic delay,Heart failure,Transthyretin amyloidosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined